Peptide
CJC-1295
Overview
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that increases growth hormone and IGF-1 levels. Available with or without DAC (Drug Affinity Complex), it promotes muscle growth, fat loss, and improved recovery. Often combined with Ipamorelin.
Dosage
With DAC: 2mg per week, Without DAC: 100-200mcg 2-3x per day
Cycle Length
8-12 weeks
Benefits
- ✓Increased growth hormone levels
- ✓Enhanced muscle growth
- ✓Improved fat loss
- ✓Better sleep quality
- ✓Enhanced recovery
- ✓Improved skin elasticity
- ✓Increased bone density
- ✓Anti-aging effects
Side Effects
- ⚠Water retention
- ⚠Numbness or tingling
- ⚠Increased hunger
- ⚠Headaches
- ⚠Injection site irritation
- ⚠Possible insulin resistance
- ⚠Elevated prolactin (rare)
Post Cycle Therapy (PCT)
No PCT required
⚠️ Warning: This information is for educational purposes only. Consult with a healthcare professional before use.